32 studies found for:    Open Studies | "Gout"
Show Display Options
Rank Status Study
21 Not yet recruiting Pharmacogenetics of SGLT2 Inhibitors
Conditions: Diabetes Mellitus;   Gout;   Hyperuricemia
Intervention: Drug: Canagliflozin
22 Not yet recruiting Prospective Analgesic Compound Efficacy (PACE) Study
Conditions: Arthritis;   Tendonitis;   Gout;   Radiculopathy;   Muscle Spasms;   Synovitis;   Migraine;   Headache
Interventions: Drug: baclofen 2%;   Drug: Bupivacaine hydrochloride 1%;   Drug: Cyclobenzaprine hydrochloride 2%;   Drug: Diclofenac Sodium 3%;   Drug: Flurbiprofen 10%;   Drug: Gabapentin 6%;   Drug: Ketamine 10%;   Drug: Lidocaine 2%;   Drug: Prilocaine 2.5%;   Drug: Meloxicam 0.09%;   Drug: Sumatriptan 5%;   Drug: Tizanidine 0.1%;   Drug: Topiramate 2.5%;   Drug: Capsaicin, USP 0.0375%;   Drug: Menthol, NF 5.00 %
23 Recruiting Mild, Moderate and Severe Renal Impairment Study
Condition: Gout
Intervention: Drug: RDEA3170
24 Recruiting Effects of Fasting on Self Efficacy
Conditions: Chronic Pain;   Fibromyalgia;   Rheumatoid Arthritis;   Gout;   Headache;   Arthritis;   Gastrointestinal Diseases;   Irritable Bowel Syndrome;   Inflammatory Bowel Disease;   Cardiovascular Diseases
Intervention: Behavioral: Fasting
25 Recruiting Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome
Condition: Gout
Intervention: Drug: Febuxostat
26 Recruiting Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments
Conditions: Rheumatoid Arthritis;   Osteoarthritis;   Systemic Lupus Erythematosus;   Sjogren's Syndrome;   Scleroderma;   Spondylitis;   Gout;   Spinal Disease;   Chondrocalcinosis
Intervention:
27 Unknown  Safety and Efficacy Study of Intramuscular Uricase-PEG 20
Conditions: Gout;   Hyperuricemia
Intervention: Biological: Uricase-PEG 20
28 Recruiting Study of FYU-981 in Hyperuricemia With or Without Gout
Condition: Hyperuricemia
Interventions: Drug: FYU-981;   Drug: Placebo
29 Recruiting Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Comorbidities
Condition: Cardiovascular Disease
Interventions: Drug: Febuxostat;   Drug: Allopurinol
30 Recruiting Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout
Condition: Diabetic Nephropathy
Interventions: Drug: Topiroxostat BID, (Oral daily dosing for 28 weeks);   Drug: Placebo BID, (Oral daily dosing for 28 weeks)
31 Recruiting Role of ASICs in Human Inflammatory Pain
Conditions: Arthritis;   Osteoarthritis;   Chondrocalcinosis;   Gouty Arthritis;   Rheumatoid Arthritis
Intervention:
32 Recruiting The Effect of Uric Acid Lowering in Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Febuxostat

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-32) Next Page   
Indicates status has not been verified in more than two years